$234.47
0.41[0.18%]
At close: Apr 23
$234.47
0[0.00%]
After Hours: 4:04PM EDT
United Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of United Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/06/2024 | AM | UTHR | Q1 | $4.86 | $5.64 | — | — | $506.90M | $619.76M | — | — | Get Alert |
02/21/2024 | AM | UTHR | Q4 | $2.67 | $4.19 | $4.36 | 4.06% | $491.50M | $575.87M | $614.70M | 6.74% | Get Alert |
11/01/2023 | AM | UTHR | Q3 | $4.91 | $5.08 | $5.38 | 5.91% | $516.00M | $587.90M | $609.40M | 3.66% | Get Alert |
08/02/2023 | AM | UTHR | Q2 | $2.41 | $4.41 | $5.24 | 18.82% | $466.90M | $532.33M | $596.50M | 12.05% | Get Alert |
05/03/2023 | AM | UTHR | Q1 | $5.03 | $4.52 | $4.86 | 7.52% | $461.90M | $514.37M | $506.90M | -1.45% | Get Alert |
02/22/2023 | AM | UTHR | Q4 | $3.51 | $4.51 | $2.67 | -40.80% | $415.20M | $519.21M | $491.50M | -5.34% | Get Alert |
11/02/2022 | AM | UTHR | Q3 | $3.42 | $3.89 | $4.91 | 26.22% | $444.70M | $493.20M | $516.00M | 4.62% | Get Alert |
08/03/2022 | AM | UTHR | Q2 | $3.65 | $4.12 | $2.41 | -41.50% | $446.50M | $461.06M | $466.90M | 1.27% | Get Alert |
05/04/2022 | AM | UTHR | Q1 | $3.49 | $3.34 | $5.03 | 50.60% | $379.10M | $420.02M | $461.90M | 9.97% | Get Alert |
02/24/2022 | AM | UTHR | Q4 | $3.31 | $3.72 | $3.51 | -5.65% | $384.90M | $427.62M | $415.20M | -2.90% | Get Alert |
11/03/2021 | AM | UTHR | Q3 | $3.88 | $3.59 | $4.16 | 15.88% | $380.10M | $421.45M | $444.70M | 5.52% | Get Alert |
08/04/2021 | AM | UTHR | Q2 | $3.68 | $3.02 | $4.09 | 35.43% | $362.00M | $378.75M | $446.50M | 17.89% | Get Alert |
05/05/2021 | AM | UTHR | Q1 | $3.61 | $2.94 | $3.49 | 18.71% | $356.30M | $368.95M | $379.10M | 2.75% | Get Alert |
02/24/2021 | AM | UTHR | Q4 | $1.96 | $3.14 | $3.31 | 5.41% | $311.10M | $361.07M | $384.90M | 6.60% | Get Alert |
10/28/2020 | AM | UTHR | Q3 | $3.83 | $2.78 | $3.88 | 39.57% | $401.50M | $356.95M | $380.10M | 6.49% | Get Alert |
07/29/2020 | AM | UTHR | Q2 | $3.63 | $2.80 | $3.68 | 31.43% | $373.60M | $338.47M | $362.00M | 6.95% | Get Alert |
04/29/2020 | AM | UTHR | Q1 | $3.58 | $2.72 | $3.61 | 32.72% | $362.60M | $344.33M | $356.30M | 3.48% | Get Alert |
02/26/2020 | AM | UTHR | Q4 | $3.34 | $2.65 | $1.96 | -26.04% | $381.40M | $357.77M | $311.10M | -13.04% | Get Alert |
10/30/2019 | AM | UTHR | Q3 | $3.98 | $2.47 | $3.83 | 55.06% | $412.70M | $337.60M | $401.50M | 18.93% | Get Alert |
United Therapeutics (UTHR) is scheduled to report earnings on May 6, 2024. The last reported earnings were for reported on February 21, 2024 for Q4.
The Actual EPS was $4.36, which beat the estimate of $4.19.
The Actual Revenue was $614.7M, which beat the estimate of $575.9M.
Browse earnings estimates, EPS, and revenue on all stocks.